Clinical Trial

Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies

Recruiting
View on ClinicalTrials.gov →
Summary
This study investigates how metabolism in cancer and immune cells shapes the bone marrow environment, influences therapy resistance, and affects outcomes in hematological malignancies.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-15.
Status change: Not Yet Recruiting → Recruiting 2025-12-16
Trial Details
NCT Number NCT07189117
Lead Sponsor University Hospital, Basel, Switzerland
Conditions Hematologic Malignancy
Enrollment 350 participants
Start Date 2025-10-29
Primary Completion 2035-12 (estimated)
Study Completion 2040-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-23